Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ovarian ablation in breast cancer, 1896 to 1998: milestones along hierarchy of evidence from case report to Cochrane review.

Authors: Shannon K Laughlin-Tommaso; Elizabeth A Stewart; Brandon R Grossardt; Liliana Gazzuola Rocca; Walter A Rocca
Journal: Menopause Date: 2014-05 Impact factor: 2.953

Review 6. Adjuvant endocrine therapy for premenopausal women with breast cancer.

Authors: Shannon Puhalla; Adam Brufsky; Nancy Davidson
Journal: Breast Date: 2009-10 Impact factor: 4.380

Review 7. The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[¹⁸F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review.

Authors: John A Katzenellenbogen
Journal: Nucl Med Biol Date: 2020-02-22 Impact factor: 2.408

Review 8. Current controversies in the management of early breast cancer.

Authors: L G Estévez; M Martín; E Alba; R Colomer; F Lobo; A Lluch; E Adrover; J Albanell; A Barnadas; J García-Mata; A Llombart; M Muñoz; C Rodríguez; P Sánchez-Rovira; M A Seguí; I Tusquets
Journal: Clin Transl Oncol Date: 2007-06 Impact factor: 3.340

9. Adjuvant endocrine therapy for premenopausal women with early breast cancer.

Authors: Ting Bao; Nancy E Davidson
Journal: Breast Cancer Res Date: 2007 Impact factor: 6.466

10. Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer.

Authors: Kim Tam Bui; Melina L Willson; Shom Goel; Jane Beith; Annabel Goodwin
Journal: Cochrane Database Syst Rev Date: 2020-03-06

Review 10. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group.

Review 3. Postoperative endocrine therapy for invasive breast cancer.

Review 4. What is the current status of ovarian suppression/ablation in women with premenopausal early-stage breast cancer?

Review 6. Adjuvant endocrine therapy for premenopausal women with breast cancer.

Review 7. The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review.

Review 8. Current controversies in the management of early breast cancer.

Review 7. The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[¹⁸F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review.